期刊
JOURNAL OF NEPHROLOGY
卷 35, 期 9, 页码 2191-2204出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s40620-022-01388-9
关键词
Chronic kidney disease; End-stage kidney disease; Hemodialysis; Peritoneal dialysis; Residual renal function
Chronic kidney disease is a significant public health concern, with increasing numbers of patients progressing to end-stage kidney disease and requiring peritoneal dialysis and hemodialysis. Preserving residual renal function is crucial for improving clinical outcomes and quality of life in these patients. Residual renal function contributes to the wellbeing of end-stage kidney disease patients through various mechanisms and has beneficial effects on inflammation, anemia, malnutrition, diabetes mellitus, obesity, changes in microbiota, and cardiac diseases. Multiple strategies for preserving residual renal function are being investigated through ongoing clinical trials.
Chronic kidney disease (CKD) is one of the most important public health concerns of the century, and is associated with high rates of morbidity, mortality and social costs. CKD evolving towards end-stage kidney disease (ESKD) is on the rise resulting in a greater number of patients requiring peritoneal dialysis (PD) and hemodialysis (HD). The aim of this manuscript is to review the current literature on the interplay of residual renal function (RRF) with clinical outcomes in ESKD. The persistence of RRF is one of the most important predictors of decreased morbidity, mortality, and better quality of life in both PD and HD patients. RRF contributes to the well-being of ESKD patients through various mechanisms including higher clearance of solutes, maintenance of fluid balance, removal of uremic toxins and control of electrolytes. Furthermore, RRF has beneficial effects on inflammation, anemia, malnutrition, diabetes mellitus, obesity, changes in the microbiota, and cardiac diseases. Several strategies have been proposed to preserve RRF, such as blockade of the renin-angiotensin-aldosterone system, better blood pressure control, incremental PD and HD. Several clinical trials investigating the issue of preservation of RRF are ongoing. They are needed to broaden our understanding of the interplay of RRF with clinical outcomes in ESKD. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据